{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:21:24Z","timestamp":1761895284995},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.juro.2011.03.039","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T08:56:38Z","timestamp":1306227398000},"page":"302-309","source":"Crossref","is-referenced-by-count":24,"title":["Preclinical Study of the Novel Vascular Occluding Agent, WST11, for Photodynamic Therapy of the Canine Prostate"],"prefix":"10.1097","volume":"186","author":[{"given":"Simone","family":"Chevalier","sequence":"first","affiliation":[{"name":"Urologic Oncology Research Group, Research Institute, McGill University Health Center, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Anidjar","sequence":"additional","affiliation":[{"name":"Urologic Oncology Research Group, Research Institute, McGill University Health Center, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Scarlata","sequence":"additional","affiliation":[{"name":"Urologic Oncology Research Group, Research Institute, McGill University Health Center, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Hamel","sequence":"additional","affiliation":[{"name":"Urologic Oncology Research Group, Research Institute, McGill University Health Center, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avigdor","family":"Scherz","sequence":"additional","affiliation":[{"name":"Weizmann Institute of Science, Rehovot, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Ficheux","sequence":"additional","affiliation":[{"name":"Steba Biotech, Cedex, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Borenstein","sequence":"additional","affiliation":[{"name":"Institut Mutualiste Montsouris, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Fiette","sequence":"additional","affiliation":[{"name":"Institut Mutualiste Montsouris, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Elhilali","sequence":"additional","affiliation":[{"name":"Urologic Oncology Research Group, Research Institute, McGill University Health Center, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2011.03.039_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","article-title":"Photodynamic therapy for cancer","volume":"3","author":"Dolmans","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.juro.2011.03.039_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/153303460500400308","article-title":"A review of progress in clinical photodynamic therapy","volume":"4","author":"Huang","year":"2005","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.juro.2011.03.039_bib3","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1634\/theoncologist.11-9-1034","article-title":"Photodynamic therapy in oncology","volume":"11","author":"Triesscheijn","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.juro.2011.03.039_bib4","first-page":"572","article-title":"Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy","volume":"45","author":"Henderson","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2011.03.039_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ncpuro1274","article-title":"Photodynamic therapy for prostate cancer\u2014a review of current status and future promise","volume":"6","author":"Moore","year":"2009","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.juro.2011.03.039_bib6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/lsm.20345","article-title":"Targeted photodynamic therapy","volume":"38","author":"Solban","year":"2006","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.juro.2011.03.039_bib7","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1158\/0008-5472.CAN-06-0604","article-title":"Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer","volume":"66","author":"Solban","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2011.03.039_bib8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1751-1097.2009.00585.x","article-title":"Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy","volume":"85","author":"O'Connor","year":"2009","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.juro.2011.03.039_bib9","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1021\/ja046210j","article-title":"The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide","volume":"127","author":"Vakrat-Haglili","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.juro.2011.03.039_bib10","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1021\/jp900580e","article-title":"Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin","volume":"113","author":"Ashur","year":"2009","journal-title":"J Phys Chem A"},{"key":"10.1016\/j.juro.2011.03.039_bib11","doi-asserted-by":"crossref","first-page":"e10282","DOI":"10.1371\/journal.pone.0010282","article-title":"Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad","volume":"5","author":"Madar-Balakirski","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.juro.2011.03.039_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm940","article-title":"Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI","volume":"9","author":"Gross","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.juro.2011.03.039_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1562\/2004-06-14-RA-199.1","article-title":"WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model","volume":"81","author":"Mazor","year":"2005","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.juro.2011.03.039_bib14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1562\/0031-8655(2002)076<0438:PSINCP>2.0.CO;2","article-title":"Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers","volume":"76","author":"Chen","year":"2002","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.juro.2011.03.039_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00262-008-0527-0","article-title":"Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity","volume":"58","author":"Preise","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.juro.2011.03.039_bib16","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ijc.11002","article-title":"Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts","volume":"104","author":"Koudinova","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2011.03.039_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1562\/2004-12-01-RA-389R1.1","article-title":"Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins","volume":"81","author":"Brandis","year":"2005","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.juro.2011.03.039_bib18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1751-1097.2008.00340.x","article-title":"Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate","volume":"84","author":"Fleshker","year":"2008","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.juro.2011.03.039_bib19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1464-410X.2008.07753.x","article-title":"Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses","volume":"102","author":"Trachtenberg","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2011.03.039_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.suronc.2009.02.002","article-title":"Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer","volume":"18","author":"Ahmed","year":"2009","journal-title":"Surg Oncol"},{"key":"10.1016\/j.juro.2011.03.039_bib21","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1167\/iovs.07-0767","article-title":"Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes","volume":"49","author":"Berdugo","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.juro.2011.03.039_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1117\/12.528379","article-title":"Preclinical studies of vascular acting photosensitizer bacteriopheophorbide for the treatment of prostate cancer","volume":"5315","author":"Hetzel","year":"2004","journal-title":"Proc SPIE"},{"key":"10.1016\/j.juro.2011.03.039_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/lsm.20060","article-title":"On appropriate pathology for photothermal surgery","volume":"35","author":"Shaco-Levy","year":"2004","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.juro.2011.03.039_bib24","first-page":"2146","article-title":"Expression of vascular endothelial growth factor-A in human lymph node metastases of prostate cancer","volume":"11","author":"Ismail","year":"2004","journal-title":"Can J Urol"},{"key":"10.1016\/j.juro.2011.03.039_bib25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/lsm.20375","article-title":"Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland","volume":"38","author":"Huang","year":"2006","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.juro.2011.03.039_bib26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1667\/RR3186","article-title":"Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation","volume":"161","author":"Huang","year":"2004","journal-title":"Radiat Res"},{"key":"10.1016\/j.juro.2011.03.039_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jphotobiol.2005.01.008","article-title":"Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities","volume":"79","author":"Weersink","year":"2005","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.juro.2011.03.039_bib28","first-page":"2151","article-title":"Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy","volume":"62","author":"Dolmans","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2011.03.039_bib29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.oraloncology.2005.10.006","article-title":"Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft","volume":"42","author":"Togashi","year":"2006","journal-title":"Oral Oncol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711033064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711033064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2011.03.039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:15:50Z","timestamp":1651198550000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2011.03.039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1016\/j.juro.2011.03.039"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2011.03.039","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}